These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35693772)

  • 1. Analysis of the Efficacy and Safety of Avatrombopag Combined With MSCs for the Treatment of Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhu L; Liu J; Kong P; Gao S; Wang L; Liu H; Zhang C; Gao L; Feng Y; Chen T; Gao L; Zhang X
    Front Immunol; 2022; 13():910893. PubMed ID: 35693772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avatrombopag for the treatment of thrombocytopenia in children's patients following allogeneic hematopoietic stem-cell transplantation: A pilot study.
    Ruan Y; Cao W; Luo T; Liu X; Liu Q; Xiao Y; Wu C; Xie D; Ren Y; Wu X; Feng X
    Front Pediatr; 2023; 11():1099372. PubMed ID: 36873638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-transplant thrombocytopenia predicts engraftment time and blood products requirement in allogeneic hematopoietic stem cell transplantation patients.
    Roshandel E; Kaviani S; Hajifathali A; Soleimani M
    Transfus Apher Sci; 2020 Aug; 59(4):102810. PubMed ID: 32430259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure.
    Terrault NA; Hassanein T; Howell CD; Joshi S; Lake J; Sher L; Vargas H; McIntosh J; Tang S; Jenkins TM
    J Hepatol; 2014 Dec; 61(6):1253-9. PubMed ID: 25048952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis.
    Servais S; Baron F; Lechanteur C; Seidel L; Baudoux E; Briquet A; Selleslag D; Maertens J; Poire X; Schroyens W; Graux C; De Becker A; Zachee P; Ory A; Herman J; Kerre T; Beguin Y
    Front Immunol; 2023; 14():1106464. PubMed ID: 36817464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of mesenchymal stem cells from third-party donors in the treatment of refractory late onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplanation].
    Zhao K; Huang F; Chen XY; Chang Y; Xu N; Shi PC; Liu H; Sun J; Xiang P; Liu QF; Fan ZP
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):488-493. PubMed ID: 35968592
    [No Abstract]   [Full Text] [Related]  

  • 7. Avatrombopag for the treatment of thrombocytopenia post hematopoietic stem-cell transplantation.
    Zhou M; Qi J; Gu C; Wang H; Zhang Z; Wu D; Han Y
    Ther Adv Hematol; 2022; 13():20406207221127532. PubMed ID: 36185780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nuclear factor erythroid 2-related factor 2 agonist tert-butylhydroquinone improves bone marrow mesenchymal stromal cell function in prolonged isolated thrombocytopenia after allogeneic haematopoietic stem cell transplantation.
    Luo XY; Kong Y; Lv M; Mo XD; Wang Y; Xu LP; Zhang XH; Huang XJ; Tang FF
    Br J Haematol; 2023 Mar; 200(6):759-768. PubMed ID: 36464324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells versus mesenchymal stem cells combined with cord blood for engraftment failure after autologous hematopoietic stem cell transplantation: a pilot prospective, open-label, randomized trial.
    Xiong YY; Fan Q; Huang F; Zhang Y; Wang Y; Chen XY; Fan ZP; Zhou HS; Xiao Y; Xu XJ; Dai M; Xu N; Sun J; Xiang P; Huang XJ; Liu QF
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):236-42. PubMed ID: 24216182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact on platelet recovery of recombinant human thrombopoietin in severe aplastic anemia patients with allogeneic hematopoietic stem cell transplantation].
    Song Y; Zhou F; Song NX; Liu XM; Yu Z; Xie LN; Song XC; Li X
    Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):207-211. PubMed ID: 29562465
    [No Abstract]   [Full Text] [Related]  

  • 11. [Research Progress on Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation -Review].
    Huang AJ; Hu XX; Wang JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):270-275. PubMed ID: 28245415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis.
    Armstrong N; Büyükkaramikli N; Penton H; Riemsma R; Wetzelaer P; Huertas Carrera V; Swift S; Drachen T; Raatz H; Ryder S; Shah D; Buksnys T; Worthy G; Duffy S; Al M; Kleijnen J
    Health Technol Assess; 2020 Oct; 24(51):1-220. PubMed ID: 33108266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag.
    Tang C; Chen F; Kong D; Ma Q; Dai H; Yin J; Li Z; Chen J; Zhu X; Mao X; Wu D; Tang X
    J Hematol Oncol; 2018 Aug; 11(1):103. PubMed ID: 30115080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of avatrombopag in the management of severe and refractory chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors.
    Gao Y; Liu Q; Shen Y; Li Y; Shao K; Ye B; Shen Y; Zhou Y; Wu D
    Platelets; 2022 Oct; 33(7):1024-1030. PubMed ID: 35040375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation.
    Karataş A; Göker H; Demiroğlu H; Malkan ÜY; Velet M; Çınar OE; Erdoğdu B; Karadeniz M; Sayınalp N; Aksu S; Haznedaroğlu İC; Özcebe Oİ; Büyükaşık Y
    Turk J Med Sci; 2022 Apr; 52(2):413-419. PubMed ID: 36161632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of haploidentical allogeneic bone marrow hematopoietic stem cell transplantation combined with umbilical cord blood derived mesenchymal stem cells for severe aplastic anemia].
    Xu LX; Cao YB; Wang ZH; Liu ZY; Liu B; Zhao DD; DA WM; Gao CJ; Wu XX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1241-5. PubMed ID: 22040980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Shahzad M; Siddiqui RS; Anwar I; Chaudhary SG; Ali T; Naseem M; Ahmed TF; Ahmed Z; Khurana S; Ahmed N; Balusu R; Singh AK; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
    Transplant Cell Ther; 2021 Oct; 27(10):877.e1-877.e8. PubMed ID: 34284148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical observation of haploidentical-hematopoietic stem cell transplantation combined with human umbilical cord-derived mesenchymal stem cells for severe aplastic anemia-II].
    Xu LX; Liu ZY; Wu YM; Cao YB; Li XH; Yan B; Yang XL; DA WM; Wu XX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):774-8. PubMed ID: 24989293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of Gaucher disease with allogeneic hematopoietic stem cell transplantation: report of three cases and review of literatures].
    Tang X; Luan Z; Wu N; Zhang B; Jing Y; Du H; Lu W; Xu S
    Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):810-6. PubMed ID: 26758318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of mesenchymal stem cells co-infusion in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Li T; Luo C; Zhang J; Wei L; Sun W; Xie Q; Liu Y; Zhao Y; Xu S; Wang L
    Stem Cell Res Ther; 2021 Apr; 12(1):246. PubMed ID: 33879242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.